U Menon

Summary

Affiliation: University College London
Country: UK

Publications

  1. ncbi Ovarian cancer screening
    Farhad Alexander-Sefre
    Department of Gynaecological Oncology, St Bartholomew's and the Royal London Medical and Dental School, London EC1A 7BE
    Hosp Med 63:210-3. 2002
  2. ncbi The sine qua non of discovering novel biomarkers for early detection of ovarian cancer: carefully selected preclinical samples
    Ian Jacobs
    Gynaecological Oncology, UCL EGA Institute for Women s Health, London, UK
    Cancer Prev Res (Phila) 4:299-302. 2011
  3. ncbi Impact on mortality and cancer incidence rates of using random invitation from population registers for recruitment to trials
    Matthew Burnell
    Gynaecological Oncology, EGA Institute for Women s Health, University College London, London, UK
    Trials 12:61. 2011
  4. ncbi OSPACS: Ultrasound image management system
    Will Stott
    Gynaecological Cancer Research Laboratories, UCL EGA Institute for Women s Health, University College London, Paul O Gorman Building, Gower Street, London WC1E 6BT, UK
    Source Code Biol Med 3:11. 2008
  5. ncbi Recruitment to multicentre trials--lessons from UKCTOCS: descriptive study
    Usha Menon
    Gynaecological Oncology, UCL EGA Institute for Women s Health, London W1T 7DN
    BMJ 337:a2079. 2008
  6. ncbi Ovarian cancer: challenges of early detection
    Usha Menon
    Gynaecological Cancer Research Centre, UCL Elizabeth Garrett Institute of Women's Health, Maple House, London, UK
    Nat Clin Pract Oncol 4:498-9. 2007
  7. ncbi Views of BRCA gene mutation carriers on preimplantation genetic diagnosis as a reproductive option for hereditary breast and ovarian cancer
    U Menon
    Gynaecological Oncology, UCL Institute for Women s Health, 149 Tottenham Court Road, London, UK
    Hum Reprod 22:1573-7. 2007
  8. ncbi Decline in use of hormone therapy among postmenopausal women in the United Kingdom
    Usha Menon
    Department of Gynaecological Oncology, UCL Institute for Women s Health, London, UK
    Menopause 14:462-7. 2007
  9. ncbi Assessing the malignant potential of ovarian inclusion cysts in postmenopausal women within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a prospective cohort study
    A Sharma
    Gynaecological Cancer Research Centre, University College London, EGA Institute for Women s Health, UK
    BJOG 119:207-19. 2012
  10. ncbi Prevalence, frequency and problem rating of hot flushes persist in older postmenopausal women: impact of age, body mass index, hysterectomy, hormone therapy use, lifestyle and mood in a cross-sectional cohort study of 10,418 British women aged 54-65
    M S Hunter
    Department of Psychology, Institute of Psychiatry, King s College London, London, UK
    BJOG 119:40-50. 2012

Detail Information

Publications64

  1. ncbi Ovarian cancer screening
    Farhad Alexander-Sefre
    Department of Gynaecological Oncology, St Bartholomew's and the Royal London Medical and Dental School, London EC1A 7BE
    Hosp Med 63:210-3. 2002
    ..However, the results so far do not justify routine screening until the impact of screening on mortality has been assessed in larger randomized trials...
  2. ncbi The sine qua non of discovering novel biomarkers for early detection of ovarian cancer: carefully selected preclinical samples
    Ian Jacobs
    Gynaecological Oncology, UCL EGA Institute for Women s Health, London, UK
    Cancer Prev Res (Phila) 4:299-302. 2011
    ..This research has important implications for the future design of cancer biomarker studies...
  3. ncbi Impact on mortality and cancer incidence rates of using random invitation from population registers for recruitment to trials
    Matthew Burnell
    Gynaecological Oncology, EGA Institute for Women s Health, University College London, London, UK
    Trials 12:61. 2011
    ..This report assesses the extent of the HVE still prevalent in UKCTOCS and considers how certain shortfalls in mortality and incidence can be related to differences in socioeconomic status...
  4. ncbi OSPACS: Ultrasound image management system
    Will Stott
    Gynaecological Cancer Research Laboratories, UCL EGA Institute for Women s Health, University College London, Paul O Gorman Building, Gower Street, London WC1E 6BT, UK
    Source Code Biol Med 3:11. 2008
    ..However, these systems are usually not suitable for managing large collections of anonymized ultrasound images gathered during a clinical screening trial...
  5. ncbi Recruitment to multicentre trials--lessons from UKCTOCS: descriptive study
    Usha Menon
    Gynaecological Oncology, UCL EGA Institute for Women s Health, London W1T 7DN
    BMJ 337:a2079. 2008
    ..To describe the factors that contributed to successful recruitment of more than 200,000 women to the UK Collaborative Trial of Ovarian Cancer Screening, one of the largest ever randomised controlled trials...
  6. ncbi Ovarian cancer: challenges of early detection
    Usha Menon
    Gynaecological Cancer Research Centre, UCL Elizabeth Garrett Institute of Women's Health, Maple House, London, UK
    Nat Clin Pract Oncol 4:498-9. 2007
  7. ncbi Views of BRCA gene mutation carriers on preimplantation genetic diagnosis as a reproductive option for hereditary breast and ovarian cancer
    U Menon
    Gynaecological Oncology, UCL Institute for Women s Health, 149 Tottenham Court Road, London, UK
    Hum Reprod 22:1573-7. 2007
    ..This is the first report on views of BRCA gene mutation carriers on use of PGD for HBOC...
  8. ncbi Decline in use of hormone therapy among postmenopausal women in the United Kingdom
    Usha Menon
    Department of Gynaecological Oncology, UCL Institute for Women s Health, London, UK
    Menopause 14:462-7. 2007
    ..This study documents recent trends in HT use in postmenopausal women in the United Kingdom...
  9. ncbi Assessing the malignant potential of ovarian inclusion cysts in postmenopausal women within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a prospective cohort study
    A Sharma
    Gynaecological Cancer Research Centre, University College London, EGA Institute for Women s Health, UK
    BJOG 119:207-19. 2012
    ..To evaluate the malignant potential of ultrasound-detected ovarian inclusion cysts in the development of ovarian cancer (OC) in postmenopausal women...
  10. ncbi Prevalence, frequency and problem rating of hot flushes persist in older postmenopausal women: impact of age, body mass index, hysterectomy, hormone therapy use, lifestyle and mood in a cross-sectional cohort study of 10,418 British women aged 54-65
    M S Hunter
    Department of Psychology, Institute of Psychiatry, King s College London, London, UK
    BJOG 119:40-50. 2012
    ..We report on these variables in a large UK cohort of postmenopausal women...
  11. ncbi Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status
    R Manchanda
    Department of Gynaecological Oncology, EGA Institute for Women s Health, UCL, London, UK
    BJOG 118:814-24. 2011
    ..To compare surgical outcomes and occult cancer rates at risk-reducing salpingo-oophorectomy in BRCA carriers and high-risk women who had not undergone genetic testing...
  12. ncbi A comparison of national cancer registry and direct follow-up in the ascertainment of ovarian cancer
    N Macdonald
    Department of Gynaecological Oncology, St Bartholomew s Hospital, London, UK
    Br J Cancer 80:1826-7. 1999
    ..NHSCR ascertainment was incomplete and direct follow-up provided additional information. These findings have implications for interpretation of national cancer statistics and for use of the NHSCR in research trials...
  13. ncbi Novel one-stop multidisciplinary follow-up clinic significantly improves cancer risk management in BRCA1/2 carriers
    G Pichert
    Clinical Genetics Department, Guy s and St Thomas NHS Foundation Trust, Guys Hospital, 7th Floor Borough Wing, Great Maze Pond Road, SE1 9RT, London, UK
    Fam Cancer 9:313-9. 2010
    ..001). Our novel MDOSC designed to devise an individually tailored cancer risk management strategy had a high uptake amongst our BRCA1/2 carriers. Attendance resulted in improved breast and ovarian cancer risk management...
  14. ncbi Recent developments in ovarian cancer screening
    U Menon
    Gynaecology Cancer Research Unit, St Bartholomew s and the Royal London Medical and Dental School, London, UK
    Curr Opin Obstet Gynecol 12:39-42. 2000
    ..Although the results do not justify ovarian cancer screening in the general population, the data support the need for a larger randomized trial powered to assess the impact of screening on mortality...
  15. ncbi Feasibility of screening for ovarian cancer using symptoms as selection criteria
    B D Rufford
    Department of Gynaecological Oncology, The Royal Marsden NHS Foundation Trust, London, UK
    BJOG 114:59-64. 2007
    ..Failure to recognise these symptoms may result in a delay in referral and diagnosis. We assess the feasibility of screening for ovarian cancer using symptoms as selection criteria...
  16. ncbi Postmenopausal women undergoing transvaginal ultrasound screening prefer not to have chaperones
    A Sharma
    Department of Gynaecological Oncology, Institute of Women s Health, UCL, London, UK
    BJOG 113:954-7. 2006
    ..Of greater consequence to women was the gender of the ultrasonographer, with 83.3% expressing a preference for a female ultrasonographer. This needs to be considered in making decisions about allocation of scarce resources...
  17. ncbi Ovarian cancer screening in the general population
    U Menon
    Gynaecology Cancer Research Unit, St Bartholomew s and the Royal London Medical and Dental School, London, UK
    Curr Opin Obstet Gynecol 13:61-4. 2001
    ..A randomized control trial to definitively answer this question is now underway in the UK. This study also addresses the issues of target population, compliance, health economics and physical and psychological morbidity of screening...
  18. ncbi Preanalytic influence of sample handling on SELDI-TOF serum protein profiles
    John F Timms
    Translational Research Laboratory, Institute of Women s Health, University College London, London, United Kingdom
    Clin Chem 53:645-56. 2007
    ..We investigated whether older collections with longer sample transit times yield useful protein profiles, and sought to establish the most feasible collection methods for future clinical proteomic studies...
  19. ncbi Circulating methylated DNA: a new generation of tumor markers
    Martin Widschwendter
    Department of Gynaecological Oncology, UCL Elizabeth Garrett Institute for Women's Health, University College London, London, United Kingdom
    Clin Cancer Res 12:7205-8. 2006
  20. ncbi Epigenotyping in peripheral blood cell DNA and breast cancer risk: a proof of principle study
    Martin Widschwendter
    Department of Gynecological Oncology, UCL Institute for Women s Health, University College London, London, United Kingdom
    PLoS ONE 3:e2656. 2008
    ..However, whether DNA methylation in normal unrelated cells is associated with BC risk and whether these imprints can be related to factors which can be modified by the environment, is unclear...
  21. ncbi Hereditary non-polyposis colorectal cancer or Lynch syndrome: the gynaecological perspective
    Ranjit Manchanda
    Department of Gynaecological Oncology, Institute for Women s Health, University College London, London, UK
    Curr Opin Obstet Gynecol 21:31-8. 2009
    ..This review covers the gynaecological aspects of managing women with HNPCC: diagnostic criteria, molecular tests for diagnosis, cancer risks and different strategies for surveillance and prevention...
  22. ncbi Screening for ovarian cancer
    Adam N Rosenthal
    Institute for Women s Health, University College London, Elizabeth Garrett Anderson Hospital, London, UK
    Clin Obstet Gynecol 49:433-47. 2006
    ..Current screening tests, clinical trials in the general and high-risk populations, screening acceptability and costs are reviewed in this article...
  23. ncbi An epigenetic signature in peripheral blood predicts active ovarian cancer
    Andrew E Teschendorff
    Medical Genomics Group, University College London Cancer Institute, University College London, London, United Kingdom
    PLoS ONE 4:e8274. 2009
    ..However, to date no study has evaluated the diagnostic and predictive potential of such markers in a large case control cohort and on a genome-wide basis...
  24. ncbi HOXA methylation in normal endometrium from premenopausal women is associated with the presence of ovarian cancer: a proof of principle study
    Martin Widschwendter
    Department of Gynecological Oncology, Institute for Women s Health, University College London, United Kingdom
    Int J Cancer 125:2214-8. 2009
    ....
  25. ncbi Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohort
    Ian Jacobs
    Gynaecological Oncology, UCL EGA Institute for Women s Health, London, UK
    Lancet Oncol 12:38-48. 2011
    ..Transvaginal ultrasound (TVS) is a possible screening test, but there have been no large-scale studies. We report the performance of TVS screening in a large cohort...
  26. ncbi Peptides generated ex vivo from serum proteins by tumor-specific exopeptidases are not useful biomarkers in ovarian cancer
    John F Timms
    Institute for Women s Health, University College London, London, UK
    Clin Chem 56:262-71. 2010
    ..We tested 2 complementary serum profiling strategies to see if similar peptides could be found that discriminate ovarian cancer from benign cases and healthy controls...
  27. ncbi Screening for ovarian cancer
    Usha Menon
    Gynaecology Oncology Unit, Bart's and the London Queen Mary's School of Medicine and Dentistry, London, UK
    Best Pract Res Clin Obstet Gynaecol 16:469-82. 2002
    ..In addition, trials in the high-risk population aimed at optimizing the current strategy have commenced in both the USA and the UK...
  28. ncbi DNA methylation of polycomb group target genes in cores taken from breast cancer centre and periphery
    Evangelia Ourania Fourkala
    Department of Gynaecological Oncology, Institute for Women s Health, University College London, 1st Floor, Maple House, 149 Tottenham Court Road, London, W1T 7DN, UK
    Breast Cancer Res Treat 120:345-55. 2010
    ..Further work will reveal if methylation of PCGT genes will serve as a robust means for the clinical detection and assessment of breast cancer...
  29. ncbi Serum oestrogen receptor alpha and beta bioactivity are independently associated with breast cancer: a proof of principle study
    M Widschwendter
    The Institute for Women s Health, University College London, London, UK
    Br J Cancer 101:160-5. 2009
    ..In this study, we analysed the capacity of serum from breast cancer cases and controls to transactivate the oestrogen receptor alpha (ER-alpha) and beta (ER-beta)...
  30. ncbi Influences on multidisciplinary team decision-making
    A Lanceley
    Gynaecological Cancer Research Centre, Institute for Women s Health, University College London, London, United Kingdom
    Int J Gynecol Cancer 18:215-22. 2008
    ..Practitioners' sphere of expertise, Department of Health policy, and familiarity of the team with the patient are key factors in shaping decision-making in MDMs...
  31. ncbi Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
    Usha Menon
    Gynaecological Oncology, University College London Elizabeth Garrett Anderson Institute for Women s Health, London, UK
    Lancet Oncol 10:327-40. 2009
    ..This report summarises the outcome of the prevalence (initial) screen in UKCTOCS...
  32. ncbi Ovarian cancer screening
    Usha Menon
    Gynaecology Cancer Research Centre, Department of Gynaecological Oncology, Institute of Women's Health, University College London, London, UK
    CMAJ 171:323-4. 2004
  33. ncbi Screening for gynaecological cancers
    A Sharma
    Department of Gynaecological Oncology, Institute of Women s Health, University College London, 149, Tottenham Court Road, London W1T 7DN, UK
    Eur J Surg Oncol 32:818-24. 2006
    ..This review covers advances in cervical cancer screening, strategies being investigated in ovarian cancer screening and the lack of justification in screening for endometrial, vulval and vaginal cancers...
  34. ncbi Management of women who test positive for high-risk types of human papillomavirus: the HART study
    J Cuzick
    Cancer Research UK, London, UK
    Lancet 362:1871-6. 2003
    ..We aimed to compare the detection rate and positive predictive values of HPV assay with cytology and to determine the best management strategy for HPV-positive women...
  35. ncbi Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer
    L Quaye
    Gynaecological Oncology Department, UCL EGA Institute for Women s Health, University College London, London, UK
    Br J Cancer 100:993-1001. 2009
    ..034) and a haplotype in BRAF that had a protective effect (P(global)=0.005). In conclusion, these data provide borderline evidence of association for common allelic variation in the NMI with risk of epithelial OC...
  36. ncbi Functional complementation studies identify candidate genes and common genetic variants associated with ovarian cancer survival
    Lydia Quaye
    Gynaecological Oncology Unit, UCL EGA Institute for Women s Health, University College London, UK
    Hum Mol Genet 18:1869-78. 2009
    ..In summary, a novel in vitro functional approach in ovarian cancer cells has identified RBBP8 as a gene for which both germline genetic variation and somatic alterations in tumours are associated with survival in ovarian cancer patients...
  37. ncbi The value of ovarian cancer screening
    Aarti Sharma
    Gynaecological Cancer Research Centre, Institute of Womens Health, University College London, London W1T 7DN
    Br J Hosp Med (Lond) 67:314-7. 2006
    ..This suggests that screening may impact on disease mortality. This review addresses the current methods of screening, the ongoing trials and future of screening for ovarian cancer...
  38. ncbi Laparoscopic extraperitoneal paraaortic lymphadenectomy: a study of its applications in gynecological malignancies
    G Mehra
    Clinical Research, Gynecological Oncology Unit, Barking, Havering and Redbridge NHS Trust and St. Bartholomew's Hospital, London, UK
    Gynecol Oncol 93:189-93. 2004
    ..It can be effectively applied in staging early ovarian cancers to determine the need for adjuvant chemotherapy...
  39. ncbi Surgical morbidity associated with radical trachelectomy and radical hysterectomy
    F Alexander-Sefre
    Department of Gynaecological Oncology, St Bartholomew s Hospital, North East London Gynaecological Cancer Centre, London, UK
    Gynecol Oncol 101:450-4. 2006
    ..To examine intra-operative, short and longer term morbidity associated with Radical Trachelectomy (RT) within our cohort of patients, compared with conventional Radical Hysterectomy (RH)...
  40. ncbi Progress and challenges in screening for early detection of ovarian cancer
    Ian J Jacobs
    Department of Gynaecological Oncology, Cancer Institute, Bart s and The London, Queen Mary s School of Medicine and Dentistry, London EC1M 6GR, United Kingdom
    Mol Cell Proteomics 3:355-66. 2004
    ..There is a sound basis for optimism that further developments in serum proteomic analysis will provide powerful methods for screening in ovarian cancer and many other diseases...
  41. ncbi Prospective study using the risk of ovarian cancer algorithm to screen for ovarian cancer
    Usha Menon
    Department of Gynecological Oncology, Institute of Women's Health, University College London
    J Clin Oncol 23:7919-26. 2005
    ..It is being used in the United Kingdom Collaborative Trial of Ovarian Cancer Screening and in the United States in both the Cancer Genetics Network and the Gynecology Oncology Group trials of high-risk women...
  42. ncbi A breast cancer fear scale: psychometric development
    Victoria L Champion
    School of Nursing, Indiana University, USA
    J Health Psychol 9:753-62. 2004
    ..All items loaded on a single factor and theoretical relationships were verified by linear and logistic regression. The Cronbach alpha for the scale was.91...
  43. ncbi Consortium analysis of 7 candidate SNPs for ovarian cancer
    Susan J Ramus
    Translational Research Laboratory, University College London EGA Institute for Women s Health, London, United Kingdom
    Int J Cancer 123:380-8. 2008
    ..These null results for SNPs identified from relatively large initial studies shows the importance of replicating associations by a consortium approach...
  44. ncbi Calculation of the risk of ovarian cancer from serial CA-125 values for preclinical detection in postmenopausal women
    Steven J Skates
    Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
    J Clin Oncol 21:206s-210s. 2003
    ..We conducted a study to assess the screening performance of the risk of ovarian cancer calculation based on serial CA-125 levels from prospectively collected serum samples compared with a fixed CA-125 cutoff...
  45. ncbi Comparisons of tailored mammography interventions at two months postintervention
    Victoria L Champion
    Indiana University School of Nursing, Indianapolis 46202 5107, USA
    Ann Behav Med 24:211-8. 2002
    ..5. Logistic regression indicates that postintervention mammography status in all three intervention groups was significantly better than usual care, with odds ratios ranging from 1.66 (telephone only) to 2.16 (telephone plus mail)...
  46. ncbi Health-related research among Amish women: a review of findings
    Melissa K Thomas
    Community Outreach, Grant Riverside Methodist Hospitals, 3726A Olentangy River Road, Columbus, OH 43214, USA
    Curr Womens Health Rep 2:208-13. 2002
    ..It is imperative that more evidence-based research be conducted to determine the cultural aspects and other factors that may influence health in this population...
  47. ncbi Beliefs associated with fecal occult blood test and colonoscopy use at a worksite colon cancer screening program
    Usha Menon
    University of Utah College of Nursing, Salt Lake City, UT 84112, USA
    J Occup Environ Med 45:891-8. 2003
    ..Findings may be used to develop interventions designed to improve CRC screening rates...
  48. ncbi Colorectal cancer screening: an overview of current trends
    Susan M Rawl
    Indiana University School of Nursing, 1111 Middle Drive, NU 338, Indianapolis, IN 46202, USA
    Nurs Clin North Am 37:225-45, v. 2002
    ..S. population. Nurses have a significant role to play in assisting individuals to incorporate regular colorectal cancer screening into their health maintenance routines...
  49. ncbi Comparison of tailored interventions to increase mammography screening in nonadherent older women
    Victoria Champion
    Indiana University School of Nursing, 1111 Middle Drive, Indianapolis, IN 46202, USA
    Prev Med 36:150-8. 2003
    ..Recent increases in mammography use have led to a decrease in mortality from breast cancer...
  50. ncbi Population-based cancer screening
    Victoria L Champion
    Indiana University of Indianapolis, Indianapolis, IN, USA
    Oncol Nurs Forum 29:853-61. 2002
    ..To provide an overview of current issues surrounding the prevention of and screening for lung, breast, cervical, colorectal, ovarian, prostate, and skin cancer...
  51. ncbi Screening for ovarian cancer
    Sara Lewis
    Gynaecology Oncology Unit, Bart s and The London, Queen Mary s School of Medicine and Dentistry, UK
    Expert Rev Anticancer Ther 3:55-62. 2003
    ..Large randomized trials are now underway to provide definitive data on the impact of screening on mortality and address morbidity, health economics and psychosocial issues...
  52. ncbi Interactive, culturally sensitive education on colorectal cancer screening
    Usha Menon
    University of Illinois at Chicago, Chicago, Illinois 60625, USA
    Med Care 46:S44-50. 2008
    ..Increasing colorectal cancer screening (CRCS) can have a substantial positive impact on morbidity and mortality...
  53. ncbi The effect of telephone versus print tailoring for mammography adherence
    Victoria Champion
    Indiana University, School of Nursing, 1111 Middle Drive, Indianapolis, IN 46202, United States
    Patient Educ Couns 65:416-23. 2007
    ..The purpose of this intervention was to increase mammography adherence in women who had not had a mammogram in the last 15 months...
  54. ncbi Breast and cervical cancer screening practices and inventions among Chinese, Japanese, and Vietnamese Americans
    Frances Lee-Lin
    School of Nursing, Oregon Health and Science University, Portland, USA
    Oncol Nurs Forum 32:995-1003. 2005
    ..To review research on breast and cervical cancer screening practices among Chinese, Japanese, and Vietnamese Americans...
  55. ncbi Health belief model variables as predictors of progression in stage of mammography adoption
    Usha Menon
    University of Illinois Chicago, College of Nursing, 845 S Damen Avenue, MC 802, Chicago, IL 60612, USA
    Am J Health Promot 21:255-61. 2007
    ..Identify predictors of change in mammography stage for nonadherent women so that appropriate stage-based interventions can be developed...
  56. ncbi Development of a self-efficacy scale for mammography
    Victoria Champion
    Indiana University, School of Nursing, Indianapolis, IN, USA
    Res Nurs Health 28:329-36. 2005
    ..Cronbach alpha was used to test internal consistency reliability. A Cronbach alpha coefficient of .87 was obtained. The mammography self-efficacy scale evidenced content and construct validity...
  57. ncbi Breast cancer beliefs and mammography screening practices among Chinese American immigrants
    Frances Lee-Lin
    School of Nursing, Oregon Health and Science University, Portland, OR 97239, USA
    J Obstet Gynecol Neonatal Nurs 36:212-21. 2007
    ..To explore knowledge and beliefs (perceived risk factors, susceptibility, benefits, common barriers, and cultural barriers) in relation to mammography screening practices among Chinese American women...
  58. ncbi Perceptions of colon cancer screening by stage of screening test adoption
    Usha Menon
    University of Illinois Chicago College of Nursing, Chicago, IL 60612, USA
    Cancer Nurs 30:178-85. 2007
    ..As such, this study is one of very few to quantify beliefs across stages of colorectal cancer and identify significant differences across stages, laying the foundation for the development and testing of stage-based interventions...
  59. ncbi Health behaviors in cancer survivors
    Deborah K Mayer
    The Institute for Clinical Research and Health Policy Studies, Tufts New England Medical Center, Boston, MA, USA
    Oncol Nurs Forum 34:643-51. 2007
    ..To describe health behaviors of cancer survivors by cancer diagnosis and to compare them to people without a personal or family cancer history...
  60. ncbi A cost-effectiveness comparison of three tailored interventions to increase mammography screening
    Robert M Saywell
    Department of Family Medicine and Bowen Research Center, Indiana University School of Medicine, Indianapolis, Indiana 46202 5102, USA
    J Womens Health (Larchmt) 13:909-18. 2004
    ..This study examined the cost-effectiveness of three combinations of tailored telephone and mailed intervention strategies for increasing adherence to mammography...
  61. ncbi Gynaecological ultrasonography: expertise counts
    Usha Menon
    Lancet Oncol 9:88-9. 2008
  62. ncbi Motivational interviewing and colorectal cancer screening: a peek from the inside out
    Stephanie Wahab
    Portland State University, Graduate School of Social Work, Portland, OR 97207, USA
    Patient Educ Couns 72:210-7. 2008
    ..We discuss in this paper the training and supervision of study interventionists, in order to enhance practice and research knowledge concerned with fidelity issues in motivational interview interventions...
  63. ncbi Screening practices in cancer survivors
    Deborah K Mayer
    Institute for Clinical Research and Health Policy Studies, Tufts New England Medical Center, 750 Washington Street 345, Boston, MA 02111, USA
    J Cancer Surviv 1:17-26. 2007
    ..The purpose of this study was to examine the impact of a cancer diagnosis on survivors' screening beliefs and practices compared to those without a cancer history...
  64. ncbi Tailored interventions for screening mammography among a sample of initially non-adherent women: when is a booster dose important?
    Celette Sugg Skinner
    Department of Surgery, Duke University Medical Center and Program in Prevention, Detection and Control Research, Duke University Comprehensive Cancer, 2424 Erwin Rd, Ste 602, DUMC 2715, Durham, NC 27705, USA
    Patient Educ Couns 65:87-94. 2007
    ..To assess added value of a booster dose of a tailored mammography intervention...